Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2009 2
2010 3
2012 4
2013 2
2014 2
2015 1
2016 2
2017 2
2019 3
2020 9
2021 8
2022 2
2023 10
2024 24
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
A Novel Bispecific Antibody Targeting EGFR and cMet Is Effective against EGFR Inhibitor-Resistant Lung Tumors.
Moores SL, Chiu ML, Bushey BS, Chevalier K, Luistro L, Dorn K, Brezski RJ, Haytko P, Kelly T, Wu SJ, Martin PL, Neijssen J, Parren PW, Schuurman J, Attar RM, Laquerre S, Lorenzi MV, Anderson GM. Moores SL, et al. Among authors: chevalier k. Cancer Res. 2016 Jul 1;76(13):3942-53. doi: 10.1158/0008-5472.CAN-15-2833. Epub 2016 May 23. Cancer Res. 2016. PMID: 27216193
Amivantamab (JNJ-61186372), an Fc Enhanced EGFR/cMet Bispecific Antibody, Induces Receptor Downmodulation and Antitumor Activity by Monocyte/Macrophage Trogocytosis.
Vijayaraghavan S, Lipfert L, Chevalier K, Bushey BS, Henley B, Lenhart R, Sendecki J, Beqiri M, Millar HJ, Packman K, Lorenzi MV, Laquerre S, Moores SL. Vijayaraghavan S, et al. Among authors: chevalier k. Mol Cancer Ther. 2020 Oct;19(10):2044-2056. doi: 10.1158/1535-7163.MCT-20-0071. Epub 2020 Aug 3. Mol Cancer Ther. 2020. PMID: 32747419
[All about JAK inhibitors].
Grange L, Barde F, Montardi C, Chevalier K. Grange L, et al. Among authors: chevalier k. Rev Med Interne. 2024 Sep;45(9S1):S9-S12. doi: 10.1016/S0248-8663(24)00775-6. Rev Med Interne. 2024. PMID: 39341630 French. No abstract available.
Myositis as a manifestation of SARS-CoV-2.
Beydon M, Chevalier K, Al Tabaa O, Hamroun S, Delettre AS, Thomas M, Herrou J, Riviere E, Mariette X. Beydon M, et al. Among authors: chevalier k. Ann Rheum Dis. 2021 Mar;80(3):e42. doi: 10.1136/annrheumdis-2020-217573. Epub 2020 Apr 23. Ann Rheum Dis. 2021. PMID: 32327427 No abstract available.
Treatment of mixed connective tissue disease: A multicenter retrospective study.
Chevalier K, Thoreau B, Michel M, Godeau B, Agard C, Papo T, Sacre K, Seror R, Mariette X, Cacoub P, Benhamou Y, Levesque H, Goujard C, Lambotte O, Bonnotte B, Samson M, Ackermann F, Schmidt J, Duhaut P, Jean-Emmanuel K, Hanslik T, Costedoat-Chalumeau N, Terrier B, Regent A, Dunogue B, Cohen P, Guern VL, Hachulla E, Chaigne B, Mouthon L. Chevalier K, et al. J Autoimmun. 2025 May;153:103420. doi: 10.1016/j.jaut.2025.103420. Epub 2025 Apr 16. J Autoimmun. 2025. PMID: 40245724 Free article.
[Common situations in internal medicine].
Grange L, Barde F, Montardi C, Chevalier K. Grange L, et al. Among authors: chevalier k. Rev Med Interne. 2024 Sep;45(9S1):S13-S16. doi: 10.1016/S0248-8663(24)00776-8. Rev Med Interne. 2024. PMID: 39341627 French. No abstract available.
[A neurological disorder during pregnancy].
Chevalier K, Stammler R, Paulet R. Chevalier K, et al. Rev Med Interne. 2021 Aug;42(8):581-582. doi: 10.1016/j.revmed.2021.02.004. Epub 2021 Feb 26. Rev Med Interne. 2021. PMID: 33648777 French. No abstract available.
73 results